Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7777)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 21, 2021 (publication date) through Jul 5, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yu J, Wang Z, Zhang H, Wang Y, Li DQ. Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma. World J Gastroenterol 2021; 27(43): 7546-7562 [PMID: 34887648 DOI: 10.3748/wjg.v27.i43.7546] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i43/7546.htm |
| Number | Citing Articles |
| 1 |
Jinyan Chen, Rongsen Wang, Huigang Li, Jiancai Sun, Ruijie Zhao, Jianyong Zhuo, Zuyuan Lin, Chiyu He, Xingzhu Chen, Jun Li, Leyi Chen, Xudong Yang, Xuyong Wei, Shusen Zheng, Xiao Xu, Di Lu. Mesenchymal circulating tumor cells as prognostic markers in HCC Post-Transplantation: Sirolimus as a potential therapeutic Modulator. European Journal of Surgical Oncology 2025; 51(9): 110147 doi: 10.1016/j.ejso.2025.110147
|
| 2 |
Mohammad S. Alzahrani, Bandar Almutairy, Yusuf S. Althobaiti, Hashem O. Alsaab. Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA. Cell Biochemistry and Biophysics 2024; 82(3): 1947 doi: 10.1007/s12013-024-01395-6
|
| 3 |
Faris Alrumaihi. Role of Liquid Biopsy for Early Detection, Prognosis, and Therapeutic Monitoring of Hepatocellular Carcinoma. Diagnostics 2025; 15(13): 1655 doi: 10.3390/diagnostics15131655
|
| 4 |
Saade Abdalkareem Jasim, Omar dheyauldeen salahdin, H. Malathi, Neha Sharma, Safia Obaidur Rab, Zafar Aminov, Atreyi Pramanik, Israa Hussein Mohammed, Mohammed Abed Jawad, Benien C. Gabel. Targeting Hepatic Cancer Stem Cells (CSCs) and Related Drug Resistance by Small Interfering RNA (siRNA). Cell Biochemistry and Biophysics 2024; 82(4): 3031 doi: 10.1007/s12013-024-01423-5
|
| 5 |
Tasfik Ul Haque Pronoy, Sharmin Aktar, Kazi Soha, Md. Arifur Rahman, Md. Nurujjaman, Farhadul Islam. Head and Neck Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 12: 63 doi: 10.1007/16833_2022_97
|
| 6 |
Indy Bui, Stavroula Baritaki, Massimo Libra, Apostolos Zaravinos, Benjamin Bonavida. Cancer Resistance Is Mediated by the Upregulation of Several Anti-Apoptotic Gene Products via the Inducible Nitric Oxide Synthase/Nitric Oxide Pathway: Therapeutic Implications. Antioxidants & Redox Signaling 2023; 39(13-15): 853 doi: 10.1089/ars.2023.0250
|
| 7 |
Yuma Hane, Takahiro Tsuchikawa, Toru Nakamura, Kanako C. Hatanaka, Katsunori Sasaki, Noriko Kawai, Shintaro Takeuchi, Kimitaka Tanaka, Yoshitsugu Nakanishi, Toshimichi Asano, Takehiro Noji, Toshiaki Shichinohe, Yutaka Hatanaka, Yoshihiko Hirohshi, Toshihiko Torigoe, Satoshi Hirano. Survivin as a Therapeutic Target for Neuroendocrine Neoplasms. Neuroendocrinology 2025; 115(3-4): 295 doi: 10.1159/000543270
|
| 8 |
Divya Janjua, Apoorva Chaudhary, Udit Joshi, Tanya Tripathi, Alok Chandra Bharti. Circulating tumor cells in solid malignancies: From advanced isolation technologies to biological understanding and clinical relevance in early diagnosis and prognosis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2025; 1880(1): 189236 doi: 10.1016/j.bbcan.2024.189236
|
| 9 |
Nermin M. Mohamed, Rania Hassan Mohamed, John F. Kennedy, Mahmoud M. Elhefnawi, Nadia M. Hamdy. A comprehensive review and in silico analysis of the role of survivin (BIRC5) in hepatocellular carcinoma hallmarks: A step toward precision. International Journal of Biological Macromolecules 2025; 311: 143616 doi: 10.1016/j.ijbiomac.2025.143616
|
| 10 |
Aya M. Ayoub, Elham Abdel-Badiea Mahmoud, Rania Hassan Mohamed, Mahmoud M. Tolba, Nahla S. Hassan, Mohamed Ghazy, Mahmoud ElHefnawi. BIRC5 as a master regulator in HCC: unraveling its role in tumor survival and therapeutic potential. Functional & Integrative Genomics 2025; 25(1) doi: 10.1007/s10142-025-01615-z
|
| 11 |
Qi Yan, Yuan-song Sun, Ran An, Fang Liu, Qi Fang, Zhen Wang, Tao Xu, Lijian Chen, Jian Du. Application and progress of the detection technologies in hepatocellular carcinoma. Genes & Diseases 2023; 10(5): 1857 doi: 10.1016/j.gendis.2022.04.003
|
| 12 |
Susanne B. Haga. Principles of Gender-Specific Medicine. 2023; : 513 doi: 10.1016/B978-0-323-88534-8.00020-1
|
| 13 |
Ruoxuan Liu, Jie Ouyang, Yinyi Gao, Bingyu Wang, Liming Li, Yi Geng, Jiewen Guo. Antiproliferative and apoptotic effects of strychnine in human hepatoma HepG2 cells and its mechanism. Materials Express 2023; 13(4): 598 doi: 10.1166/mex.2023.2394
|
| 14 |
Li Zhou, Chanjuan Zheng, Siyu Ding, Zhiyu Wang, Yiyuan Yang, Yian Wang, Guangchun He, Shujun Fu, Xiyun Deng. Lovastatin Targets the USP14–Survivin Axis to Suppress Triple-Negative Breast Cancer via Ubiquitin-Mediated Proteasomal Degradation. Cells 2025; 14(11): 816 doi: 10.3390/cells14110816
|
| 15 |
Vijayata Singh, Subhajit Pathak, Narendra Kumar, Giridhara R. Jayandharan. Development of an Optimized Promoter System for Exosomal and Naked AAV Vector-Based Suicide Gene Therapy in Hepatocellular Carcinoma. ACS Omega 2024; 9(28): 30945 doi: 10.1021/acsomega.4c03949
|